The Pharmacological Effects of Morroniside and Loganin Isolated from Liuweidihuang Wan, on MC3T3-E1 Cells

被引:68
作者
Li, Manyu [1 ]
Wang, Wei [1 ]
Wang, Ping [1 ]
Yang, Kun [1 ]
Sun, Hui [1 ]
Wang, Xijun [1 ]
机构
[1] Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Harbin 150040, Peoples R China
基金
中国国家自然科学基金;
关键词
Liuweidihuang Wan; morroniside; loganin; osteoporosis; MC3T3-E1; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; APOPTOSIS; OSTEOPOROSIS; EPIDEMIOLOGY; PREVENTION; FAMILY;
D O I
10.3390/molecules15107403
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Liuweidihuang Wan (LW), initially a well-known formula for curing "wu chi wu ruan", is commonly used nowadays for clinical treatment of Postmenopausal Osteoporosis (PO), but the identity of the effective substance(s) remains unclear. The present study was designed to evaluate the effects of morroniside and loganin isolated from LW on the proliferation, differentiation and apoptosis of MC3T3-E1 cells, as well as the possible mechanism of action. Morroniside and loganin had no effects on the proliferation of MC3T3-E1 cells, but both susbtances could improve the activity of alkaline phosphatase (ALP), and increase the contents of collagen type I and osteocalcin. Simultaneously, the mRNA expression of caspase-3, capase-9, RANKL was down-regulated and that of bcl-2 was up-regulated, which partially explains the anti-osteoporosis mechanism in MC3T3-E1 cells. In conclusion, morroniside and loganin may directly promote the differentiation and inhibit the apoptosis of MC3T3-E1 cells, and accordingly indirectly reduce bone resorption, which makes them promising natural drugs leads for treating PO in the near future.
引用
收藏
页码:7403 / 7414
页数:12
相关论文
共 38 条
[1]
AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215
[2]
BOYLE WJ, 1998, BONE, V23, P189
[3]
Chen T., 2003, TIANJIN PHARM, V15, P5
[4]
Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells [J].
Chua, CC ;
Chua, BHL ;
Chen, ZY ;
Landy, C ;
Hamdy, RC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1642 (1-2) :79-85
[5]
Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[6]
The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
[7]
Serine/threonine protein kinases and apoptosis [J].
Cross, TG ;
Scheel-Toellner, D ;
Henriquez, NV ;
Deacon, E ;
Salmon, M ;
Lord, JM .
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :34-41
[8]
Epidemiology and outcomes of osteoporotic fractures [J].
Cummings, SR ;
Melton, LJ .
LANCET, 2002, 359 (9319) :1761-1767
[9]
Epidemiology of osteoporosis [J].
Dennison, Elaine ;
Mohamed, Maysam Abdin ;
Cooper, Cyrus .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (04) :617-+
[10]
IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252